Dual Checkpoint Blockade in a Neuroendocrine Carcinoma With Dual PD-L1/PD-L2 Amplification and High Tumor Mutational Burden

Affiliations

• ¹ Division of Medical Oncology, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
• ² Division of Hematology/Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA.
• ³ Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, CA.
• ⁴ Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
• ⁵ Department of Surgery, Division of Surgical Oncology and Hepatobiliary Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
• ⁶ Departments of Radiation Oncology and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
• ⁷ Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL.